Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
<p>Abstract</p> <p>Background</p> <p>There are concerns that proton pump inhibitors (PPI) are being over prescribed in both primary and secondary care. This study aims to establish potential cost savings in a community drug scheme for a one year period according to publ...
Main Authors: | Cahir Caitriona, Fahey Tom, Tilson Lesley, Teljeur Conor, Bennett Kathleen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6963/12/408 |
Similar Items
-
Influence of generics in prescribing dynamics of proton pump inhibitors in general practice
by: Simona Cammarota, et al.
Published: (2009-03-01) -
Proton Pump Inhibitors in IPF: A Call for Clinical Trials
by: Yohannes T. Ghebre, et al.
Published: (2018-05-01) -
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
by: Mario Visconti
Published: (2015-09-01) -
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)